Skip to main content
. 2010 May 11;95(9):1572–1578. doi: 10.3324/haematol.2009.019539

Figure 4.

Figure 4.

Responses to CTAg peptides were detected post-transplantation in relapsed patients The frequencies over time of CTAg-specific T cells in relapsed myeloma patient 125M are shown (A). The gray area indicates prophylactic tapered cyclosporine treatment given during the early weeks following transplant. Paraprotein levels are plotted on the right-hand axis. CTAg-specific responses were detected in AML patient 172A shortly before relapse (B).